Association of COMT Val108/158Met genotype and cigarette smoking in pregnant women

Nicotine and Tobacco Research

Volumn 13, Issue 2, 2011, Pages 55-63

  Munafò, Marcus R ^a   Freathy, Rachel M ^a,b   Ring, Susan M ^a   St Pourcain, Beate ^a   Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ARTICLE; CIGARETTE SMOKING; DNA POLYMORPHISM; FEMALE; FIRST TRIMESTER PREGNANCY; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PREGNANT WOMAN; PRIORITY JOURNAL; SMOKING CESSATION; THIRD TRIMESTER PREGNANCY;

EID: 79251587772     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq209     Document Type: Article

References (45)

1. Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003). Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. Journal of Neuroscience, 23, 2008-2013. Retrieved from http://www.jneurosci.org/
2. Amstadter, A. B., Nugent, N. R., Koenen, K. C., Ruggiero, K. J., Acierno, R., Galea, S., et al. (2009). Association between COMT, PTSD, and increased smoking following hurricane exposure in an epidemiologic sample. Psychiatry, 72, 360-369. doi:10.1521/psyc.2009.72.4.360
3. Barnett, J. H., Scoriels, L., & Munafo, M. R. (2008). Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biological Psychiatry, 64, 137-144. doi:10.1016/j.biopsych.2008.01.005
4. Berrettini, W. H., Wileyto, E. P., Epstein, L., Restine, S., Hawk, L., Shields, P., et al. (2007). Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biological Psychiatry, 61, 111-118. doi:10.1016/j.biopsych.2006.04.030
5. Beuten, J., Payne, T. J., Ma, J. Z., & Li, M. D. (2006). Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology, 31, 675-684. doi:10.1038/sj.npp.1300997
6. Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004). The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology, 29, 1943-1961. doi:10.1038/sj.npp.1300542
7. Breitling, L. P., Dahmen, N., Illig, T., Rujescu, D., Nitz, B., Raum, E., et al. (2009). Variants in COMT and spontaneous smoking cessation: Retrospective cohort analysis of 925 cessation events. Pharmacogenetics and Genomics, 19, 657-659. doi:10.1097/FPC.0b013e32832fabf3
8. Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Scheibal, D., Hahn, E., Shiraga, S., et al. (2006). Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Archives of General Psychiatry, 63, 808-816. doi:10.1001/archpsyc.63.7.808
9. Chapman, S., & MacKenzie, R. (2010). The global research neglect of unassisted smoking cessation: Causes and consequences. PLoS Medicine, 7, e1000216. doi:10.1371/journal.pmed.1000216
10. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75, 807-821. doi:10.1086/425589
11. Clarke, H., Flint, J., Attwood, A. S., & Munafo, M. R. (2010). Association of the 5-HTTLPR genotype and unipolar depression: A meta-analysis. Psychological Medicine, 40, 1767-1778. doi:10.1017/S0033291710000516
12. Colhoun, H. M., McKeigue, P. M., & Davey Smith, G. (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865-872. doi:10.1016/S0140-6736(03)12715-8
13. Colilla, S., Lerman, C., Shields, P. G., Jepson, C., Rukstalis, M., Berlin, J., et al. (2005). Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and Genomics, 15, 393-398. doi:10.1097/01213011-200506000-00004
14. Contin, M., Martinelli, P., Mochi, M., Albani, F., Riva, R., Scaglione, C., et al. (2004). Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. Clinical Neuropharmacology, 27, 111-115. doi:10.1097/00002826-200405000-00004
15. Davey-Smith, G., Lawlor, D. A., Harbord, R., Timpson, N., Day, I., & Ebrahim, S. (2007). Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology. PLoS Medicine, 4, e352. doi:10.1371/journal.pmed.0040352
16. David, S. P., Johnstone, E., Griffiths, S. E., Murphy, M., Yudkin, P., Mant, D., et al. (2002). No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics, 12, 265-268. Retrieved from http://journals.lww.com/jpharmacogenetics/pages/default.aspx
17. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634. Retrieved from http://www.bmj.com/
18. Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191. Retrieved from http://brm.psychonomic-journals.org/
19. Golding, J., Pembrey, M., & Jones, R. (2001). ALSPAC-The Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatric and Perinatal Epidemiology, 15, 74-87. doi:10.1046/j.1365-3016.2001.00325.x
20. Guo, S., Chen da, F., Zhou, D. F., Sun, H. Q., Wu, G. Y., Haile, C. N., et al. (2007). Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology (Berlin), 190, 449-456. doi:10.1007/s00213-006-0628-4
21. Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327, 557-560. doi:10.1136/bmj.327.7414.557
22. Hughes, J. R. (2003). Motivating and helping smokers to stop smoking. Journal of General Internal Medicine, 18, 1053-1057. doi:10.1111/j.1525-1497.2003.20640.x
23. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001). Replication validity of genetic association studies. Nature Genetics, 29, 306-309. doi:10.1038/ng749
24. Johnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. F., Walton, R. T., & Munafo, M. R. (2007). Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology Biomarkers and Prevention, 16, 1065-1069. doi:10.1158/1055-9965.EPI-06-0936
25. Jonsson, E. G., Nothen, M. M., Grunhage, F., Farde, L., Nakashima, Y., Propping, P., et al. (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry, 4, 290-296. doi:10.1038/sj.mp.4000532
26. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., & Weinshilboum, R. M. (1996). Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250. doi:10.1097/00008571-199606000-00007
27. Liu, J. Z., Tozzi, F., Waterworth, D. M., Pillai, S. G., Muglia, P., Middleton, L., et al. (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics, 42, 436-440. doi:10.1038/ng.572
28. Lu, Y., Tong, S., & Oldenburg, B. (2001). Determinants of smoking and cessation during and after pregnancy. Health Promotion International, 16, 355-365. doi:10.1093/heapro/16.4.355
29. McKinney, E. F., Walton, R. T., Yudkin, P., Fuller, A., Haldar, N. A., Mant, D., et al. (2000). Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics, 10, 483-491. Retrieved from http://journals.lww.com/jpharmacogenetics/pages/default.aspx
30. Munafo, M. R. (2009). Reliability and replicability of genetic association studies. Addiction, 104, 1439-1440. doi:10.1111/j.1360-0443.2009.02662.x
31. Munafo, M. R., Clark, T., Johnstone, E., Murphy, M., & Walton, R. (2004). The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine & Tobacco Research, 6, 583-597. doi:10.1080/14622200410001734030
32. Munafo, M. R., & Flint, J. (2004). Meta-analysis of genetic association studies. Trends in Genetics, 20, 439-444. doi:10.1016/j.tig.2004.06.014
33. Munafo, M. R., Heron, J., & Araya, R. (2008). Smoking patterns during pregnancy and postnatal period and depressive symptoms. Nicotine & Tobacco Research, 10, 1609-1620. doi:10.1080/14622200802412895
34. Munafo, M. R., Johnstone, E. C., Guo, B., Murphy, M. F., & Aveyard, P. (2008). Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenetics and Genomics, 18, 121-128. doi:10.1097/FPC.0b013e3282f44daa
35. Nedic, G., Nikolac, M., Borovecki, F., Hajnsek, S., Muck-Seler, D., & Pivac, N. (2010). Association study of a functional catechol-o-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neuroscience Letters, 473, 216-219. doi:10.1016/j.neulet.2010.02.050
36. Omidvar, M., Stolk, L., Uitterlinden, A. G., Hofman, A., Van Duijn, C. M., & Tiemeier, H. (2009). The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: Retrospective and prospective analyses in a cohort study. Pharmacogenetics and Genomics, 19, 45-51. doi:10.1097/FPC.0b013e328317f3f8
37. Saccone, S. F., Pergadia, M. L., Loukola, A., Broms, U., Montgomery, G. W., Wang, J. C., et al. (2007). Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples. American Journal of Human Genetics, 80, 856-866. doi:10.1086/513703
38. Shield, A. J., Thomae, B. A., Eckloff, B. W., Wieben, E. D., & Weinshilboum, R. M. (2004). Human catechol O-methyltransferase genetic variation: Gene resequencing and functional characterization of variant allozymes. Molecular Psychiatry, 9, 151-160. doi:10.1038/sj.mp.4001386
39. Shiels, M. S., Huang, H. Y., Hoffman, S. C., Shugart, Y. Y., Bolton, J. H., Platz, E. A., et al. (2008). A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). Preventive Medicine, 47, 116-122. doi:10.1016/j.ypmed.2008.03.013
40. Szreter, S. R. S. (1984). The genesis of the Registrar-General's social classification of occupations. British Journal of Sociology, 35, 522-546. doi:10.2307/590433
41. Thorgeirsson, T. E., Gudbjartsson, D. F., Surakka, I., Vink, J. M., Amin, N., Geller, F., et al. (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics, 42, 448-453. doi:10.1038/ng.573
42. Tobacco-and-Genetics-Consortium. (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genetics, 42, 441-447. doi:10.1038/ng.571
43. Ton, T. G., Rossing, M. A., Bowen, D. J., Srinouanprachan, S., Wicklund, K., & Farin, F. M. (2007). Genetic polymorphisms in dopamine-related genes and smoking cessation in women: A prospective cohort study. Behavioral and Brain Functions, 3, 22. doi:10.1186/1744-9081-3-22
44. Twigg, L., Moon, G., Szatkowski, L., & Iggulden, P. (2009). Smoking cessation in England: Intentionality, anticipated ease of quitting and advice provision. Social Science and Medicine, 68, 610-619. doi:10.1016/j.socscimed.2008.11.032
45. Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999). Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annual Review of Pharmacology and Toxicology, 39, 19-52. doi:10.1146/annurev.pharmtox.39.1.19